Jan 10, 2024 / 03:30PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst
Good morning, everyone. Happy to introduce our next session to kick off day 3 of the JPMorgan Healthcare Conference. I'm Robbie Marcus. Pleasure to introduce Mike Carrel, CEO of AtriCure. Mike will do a little bit of a presentation, then we'll do some Q&A on stage. Mike?
Michael H. Carrel - AtriCure, Inc. - CEO, President & Director
Thanks, Robbie, and thank you, JPMorgan for having us at the conference this year. We -- it's always a great time of year to kind of kick off and explain kind of what we're doing as a business and kind of where we are in the progression of the company. So I'll kind of just kick it off, go through our forward-looking statements here for a moment. But I'd like to start on this slide because I think it's really important.
What does AtriCure do? AtriCure is really focused -- passionately focused if you just meet any of our 1,200 people in our business on healing the lives of people that have atrial fibrillation and postoperative pain. Now how big
AtriCure Inc at JPMorgan Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers